Multifocal motor neuropathy
Multifocal Motor Neuropathy (MMN) is a rare neuromuscular disease characterized by progressive, asymmetric muscle weakness and atrophy. The disease is believed to be caused by autoimmune responses leading to damage of peripheral nerves.
Symptoms[edit | edit source]
The primary symptoms of MMN are weakness and muscle atrophy, often accompanied by fasciculations and mild sensory changes. The disease typically begins in the hands and gradually progresses to other parts of the body.
Causes[edit | edit source]
The exact cause of MMN is unknown, but it is believed to be an autoimmune disease. In this case, the body's immune system mistakenly attacks the peripheral nerves, leading to their damage and the subsequent symptoms.
Diagnosis[edit | edit source]
Diagnosis of MMN is based on clinical symptoms, electromyography (EMG) findings, and the presence of anti-GM1 antibodies in the blood. However, not all patients with MMN have these antibodies, making diagnosis challenging.
Treatment[edit | edit source]
Treatment for MMN typically involves immunoglobulin therapy, which can help to reduce symptoms and slow the progression of the disease. Other treatments, such as corticosteroids and plasma exchange, may also be used, but their effectiveness is less well established.
Prognosis[edit | edit source]
The prognosis for individuals with MMN varies. Some people may experience only mild symptoms and have a normal lifespan, while others may experience significant disability. However, MMN does not typically affect life expectancy.
See also[edit | edit source]
Multifocal motor neuropathy Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD